FDA Drug recall D-1363-2020
Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room tempe…
- FDA Drug
- Class I
- terminated
- Published 2020-07-08
On 2020-07-08 the FDA classified a Class I recall of Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room tempe… by Masterpharm, citing super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1363-2020 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2020-06-09 |
| Published | 2020-07-08 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Masterpharm |
| Distribution | FL, MD |
Product
Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room temperature, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
Reason
Super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin.
Identifiers
| code_info | Lot #: 01-09-2020:13@8, Exp. 7/7/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1363-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.